Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Hospital stays become key window to start better heart failure drugs

NCT ID NCT05910437

Summary

This study looked at how often doctors prescribe newer, recommended heart failure medications when patients are hospitalized for a worsening of their condition. Researchers followed 184 adults in France to see if starting these drugs in the hospital, with close monitoring, could help control the disease. The goal was to understand real-world treatment patterns and see if this approach might reduce future hospital stays and health risks.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DECOMPENSATED HEART FAILURE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CHRU de NANCY

    Vandœuvre-lès-Nancy, 54500, France

  • Chr Metz Thionville

    Ars-Laquenexy, 57530, France

Conditions

Explore the condition pages connected to this study.